Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma.
Jin W, Yu J, Su Y, Lin H, Liu T, Chen J, Ge C, Zhao F, Geng Q, Mao L, Jiang S, Cui Y, Chen T, Jiang G, Li J, Miao C, Xiao X, Li H.
Jin W, et al. Among authors: su y.
Int J Biol Sci. 2023 Apr 23;19(7):2270-2288. doi: 10.7150/ijbs.81415. eCollection 2023.
Int J Biol Sci. 2023.
PMID: 37151886
Free PMC article.